lithium has been researched along with Anterior Choroidal Artery Infarction in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ates, N; Balcikanli, Z; Beker, MC; Caglayan, A; Caglayan, AB; Caglayan, B; Celik, S; Dasdelen, MF; Dilsiz, P; Doeppner, TR; Hermann, DM; Kilic, E; Ozbek, H; Sertel, E; Yigitbasi, T | 1 |
Chen, RW; Chuang, DM; Ren, M; Senatorov, VV | 1 |
Abe, K; Mizuki, T; Ohji, T; Terao, T | 1 |
Heigl, B; Heigl, F; Hiller, E; Kampfhammer, HP; Steinbeck, G | 1 |
Chuang, DM; Nonaka, S | 1 |
Ahuja, GK; Balaraju, KB | 1 |
6 other study(ies) available for lithium and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Infarction; Glycogen Synthase Kinase 3 beta; Lithium; Mice; Mitogen-Activated Protein Kinase Kinases; Neuroprotection; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Stroke | 2022 |
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.
Topics: Animals; Apoptosis; Blood Pressure; Body Temperature; Brain Damage, Chronic; Cerebral Infarction; Cerebrovascular Circulation; Ischemic Attack, Transient; Lithium; Male; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reperfusion | 2003 |
Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cerebral Infarction; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lithium; Lupus Erythematosus, Systemic; Mianserin; Neurocognitive Disorders; Prednisolone; Substance-Related Disorders | 1994 |
[Chronic recurrent thrombotic thrombocytopenic purpura (Moschcowitz disease). An unusual long-term course in a 43-year-old patient].
Topics: Adult; Aspirin; Biopsy; Cerebral Angiography; Cerebral Infarction; Combined Modality Therapy; Female; Follow-Up Studies; Gingiva; Humans; Lithium; Perazine; Plasma; Purpura, Thrombotic Thrombocytopenic; Recurrence | 1993 |
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
Topics: Animals; Blood Gas Analysis; Cerebral Infarction; Ischemic Attack, Transient; Lithium; Neuroprotective Agents; Rats; Rats, Wistar | 1998 |
Prior neurologic illness and the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).
Topics: Adult; Bipolar Disorder; Cerebral Infarction; Diagnosis, Differential; Dose-Response Relationship, Drug; Hemiplegia; Humans; Lithium; Male; Psychoses, Substance-Induced | 1989 |